|1.83||+0.03 / +1.67%|
Data as of 3:59pm ET
|1.83||+0.0002 / +0.01%|
The 2 analysts offering 12-month price forecasts for Oncothyreon Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +118.58% increase from the last price of 1.83.
The current consensus among 3 polled investment analysts is to Buy stock in Oncothyreon Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.